Ucinnost kyseliny fosfonomravencí na herpetická onemocnĕní
[Effectiveness of phosphonoformic acid in herpes infections]
Language Czech Country Czech Republic Media print
Document type English Abstract, Journal Article
PubMed
1316808
- MeSH
- Antiviral Agents pharmacology therapeutic use MeSH
- Foscarnet MeSH
- Herpesviridae drug effects MeSH
- Herpesviridae Infections drug therapy MeSH
- Rabbits MeSH
- Phosphonoacetic Acid analogs & derivatives pharmacology therapeutic use MeSH
- Guinea Pigs MeSH
- Animals MeSH
- Check Tag
- Rabbits MeSH
- Guinea Pigs MeSH
- Animals MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Names of Substances
- Antiviral Agents MeSH
- Foscarnet MeSH
- Phosphonoacetic Acid MeSH
The antiviral efficacy of phosphonoformic acid (PFA) was examined on tissue cultures of the human embryonal lungs against the viruses herpes simplex type 1 and 2, herpes zoster, and the human cytomegalovirus using the method of the inhibition of the cytopathic effect and against herpes simplex type 1 and 2 on the tissue cultures of Vero cells using the methods of the inhibition of plaque formation. PFA was demonstrated to inhibit the reproduction of the viruses under study in both tests on tissue cultures. In persistence studies, the cytomegalovirus was not isolated back from the cells of the human embryonal lungs, which gave evidence of its greater sensitivity to PFA. In in vivo experiments, PFA in the form of a 3% ointment suppressed herpetic dermatitis on the guinea-pig skin, when treatment started 6, 24 and 48 hours after infection. In a preliminary experiment on rabbit corneas, an ointment with 3% PFA inhibited herpetic keratoconjunctivitis in time intervals of 1 and 3 hours after infection.